Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Gross profit as a percentage of revenue
3Y CAGR
-0.3%/yr
vs +4.8%/yr prior
5Y CAGR
+13.4%/yr
Recent deceleration
Acceleration
-5.1pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | 94.19% | -2.4% |
| 2024 | 96.48% | +4.3% |
| 2023 | 92.50% | -2.7% |
| 2022 | 95.05% | +49.9% |
| 2021 | 63.40% | +26.3% |
| 2020 | 50.19% | -30.4% |
| 2019 | 72.12% | -8.3% |
| 2018 | 78.67% | -13.2% |
| 2017 | 90.63% | +7.8% |
| 2016 | 84.10% | - |